性感染症（STD）治療の世界市場 2022-2026

当レポートによると性感染症（STD）治療の市場規模は、2022年から2026年の間に134億8000万米ドルの増加が見込まれ、予測期間中にCAGR4.27％で成長すると予測しています。

当レポートでは、性感染症（STD）治療市場の全体分析、市場規模・予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析を行っています。

本レポートでは、現在の世界の市場動向と促進要因、市場全体の環境について最新の分析を行っています。市場は、STDの有病率の増加、有利な償還政策の存在、世界各国の政府によるイニシアチブの増加によって牽引されています。

本調査では、STDの迅速な診断の進歩が、今後数年間の性感染症（STD）治療市場の成長を促進する主要な理由の1つであると特定しています。また、STDや迅速パートナー療法（EPT）についての認識を高めるための様々な組織の関与の増加は、市場における相当な需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2021
• 市場の見通し：2021-2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第5章 タイプ別の市場セグメンテーション

• 市場内訳
• タイプ別比較
• ウイルス感染症 - 市場規模と予測 2021-2026
• 細菌感染症 - 市場規模と予測 2021-2026
• その他の感染症 - 市場規模と予測 2021-2026
• タイプ別の市場機会

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2021-2026
• 欧州 - 市場規模と予測 2021-2026
• アジア - 市場規模と予測 2021-2026
• その他の地域（ROW） - 市場規模と予測 2021-2026
• 米国 - 市場規模と予測 2021-2026
• 日本 - 市場規模と予測 2021-2026
• 中国 - 市場規模と予測 2021-2026
• ドイツ - 市場規模と予測 2021-2026
• 英国 - 市場規模と予測 2021-2026
• 地域情勢別の市場機会

第8章 原動力、課題、および動向

• 市場促進要因
• 市場の課題
• 推進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Aurobindo Pharma Ltd.
• Bristol Myers Squibb Co.
• C. H. Boehringer Sohn AG and Co. KG
• Dynavax Technologies Corp.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Johnson and Johnson
• Merck and Co. Inc.

第11章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Type
• Exhibits27: Data Table on Comparison by Type
• Exhibits28: Chart on Viral infections - Market size and forecast 2021-2026 ($ billion)
• Exhibits29: Data Table on Viral infections - Market size and forecast 2021-2026 ($ billion)
• Exhibits30: Chart on Viral infections - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Viral infections - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
• Exhibits33: Data Table on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
• Exhibits34: Chart on Bacterial infections - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Bacterial infections - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Other infections - Market size and forecast 2021-2026 ($ billion)
• Exhibits37: Data Table on Other infections - Market size and forecast 2021-2026 ($ billion)
• Exhibits38: Chart on Other infections - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Other infections - Year-over-year growth 2021-2026 (%)
• Exhibits40: Market opportunity by Type ($ billion)
• Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits44: Chart on Geographic comparison
• Exhibits45: Data Table on Geographic comparison
• Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
• Exhibits67: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
• Exhibits68: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits82: Market opportunity By Geographical Landscape ($ billion)
• Exhibits83: Impact of drivers and challenges in 2021 and 2026
• Exhibits84: Overview on Criticality of inputs and Factors of differentiation
• Exhibits85: Overview on factors of disruption
• Exhibits86: Impact of key risks on business
• Exhibits87: Vendors covered
• Exhibits88: Matrix on vendor position and classification
• Exhibits89: AbbVie Inc. - Overview
• Exhibits90: AbbVie Inc. - Product / Service
• Exhibits91: AbbVie Inc. - Key offerings
• Exhibits92: Aurobindo Pharma Ltd. - Overview
• Exhibits93: Aurobindo Pharma Ltd. - Product / Service
• Exhibits94: Aurobindo Pharma Ltd. - Key offerings
• Exhibits95: Bristol Myers Squibb Co. - Overview
• Exhibits96: Bristol Myers Squibb Co. - Product / Service
• Exhibits97: Bristol Myers Squibb Co. - Key offerings
• Exhibits98: C. H. Boehringer Sohn AG and Co. KG - Overview
• Exhibits99: C. H. Boehringer Sohn AG and Co. KG - Business segments
• Exhibits100: C. H. Boehringer Sohn AG and Co. KG - Key news
• Exhibits101: C. H. Boehringer Sohn AG and Co. KG - Key offerings
• Exhibits102: C. H. Boehringer Sohn AG and Co. KG - Segment focus
• Exhibits103: Dynavax Technologies Corp. - Overview
• Exhibits104: Dynavax Technologies Corp. - Product / Service
• Exhibits105: Dynavax Technologies Corp. - Key news
• Exhibits106: Dynavax Technologies Corp. - Key offerings
• Exhibits107: F. Hoffmann La Roche Ltd. - Overview
• Exhibits108: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits109: F. Hoffmann La Roche Ltd. - Key news
• Exhibits110: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits111: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits112: Gilead Sciences Inc. - Overview
• Exhibits113: Gilead Sciences Inc. - Product / Service
• Exhibits114: Gilead Sciences Inc. - Key news
• Exhibits115: Gilead Sciences Inc. - Key offerings
• Exhibits116: GlaxoSmithKline Plc - Overview
• Exhibits117: GlaxoSmithKline Plc - Business segments
• Exhibits118: GlaxoSmithKline Plc - Key news
• Exhibits119: GlaxoSmithKline Plc - Key offerings
• Exhibits120: GlaxoSmithKline Plc - Segment focus
• Exhibits121: Johnson and Johnson - Overview
• Exhibits122: Johnson and Johnson - Business segments
• Exhibits123: Johnson and Johnson - Key news
• Exhibits124: Johnson and Johnson - Key offerings
• Exhibits125: Johnson and Johnson - Segment focus
• Exhibits126: Merck and Co. Inc. - Overview
• Exhibits127: Merck and Co. Inc. - Business segments
• Exhibits128: Merck and Co. Inc. - Key news
• Exhibits129: Merck and Co. Inc. - Key offerings
• Exhibits130: Merck and Co. Inc. - Segment focus
• Exhibits131: Inclusions checklist
• Exhibits132: Exclusions checklist
• Exhibits133: Currency conversion rates for US$
• Exhibits134: Research methodology
• Exhibits135: Validation techniques employed for market sizing
• Exhibits136: Information sources
• Exhibits137: List of abbreviations

Technavio has been monitoring the sexually transmitted diseases (STD) treatment market and it is poised to grow by $13.48 bn during 2022-2026, accelerating at a CAGR of 4.27% during the forecast period. Our report on the sexually transmitted diseases (STD) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of STDs, the presence of favorable reimbursement policies, and increased initiatives by governments worldwide.

The sexually transmitted diseases (STD) treatment market analysis includes the type segment and geographic landscape.

Technavio's sexually transmitted diseases (STD) treatment market is segmented as below:

By Type

• Viral infections
• Bacterial infections
• Other infections

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted diseases (STD) treatment market growth during the next few years. Also, increasing the involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the sexually transmitted diseases (STD) treatment market covers the following areas:

• Sexually transmitted diseases (STD) treatment market sizing
• Sexually transmitted diseases (STD) treatment market forecast
• Sexually transmitted diseases (STD) treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted diseases (STD) treatment market vendors that include AbbVie Inc., Affymetrix, Aurobindo Pharma Ltd., Becton Dickinson and Co., Bristol Myers Squibb Co., C. H. Boehringer Sohn AG and Co. KG, Cepheid Inc., DiaSorin SpA, Dynavax Technologies Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Lee's Pharmaceutical Holdings Ltd., Lupin Ltd, Merck and Co. Inc., Mylan N.V, and Pfizer Inc. Also, the sexually transmitted diseases (STD) treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type
• 5.3 Viral infections - Market size and forecast 2021-2026
• Exhibit 28: Chart on Viral infections - Market size and forecast 2021-2026 ($ billion)
• Exhibit 29: Data Table on Viral infections - Market size and forecast 2021-2026 ($ billion)
• Exhibit 30: Chart on Viral infections - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Viral infections - Year-over-year growth 2021-2026 (%)
• 5.4 Bacterial infections - Market size and forecast 2021-2026
• Exhibit 32: Chart on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
• Exhibit 33: Data Table on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
• Exhibit 34: Chart on Bacterial infections - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Bacterial infections - Year-over-year growth 2021-2026 (%)
• 5.5 Other infections - Market size and forecast 2021-2026
• Exhibit 36: Chart on Other infections - Market size and forecast 2021-2026 ($ billion)
• Exhibit 37: Data Table on Other infections - Market size and forecast 2021-2026 ($ billion)
• Exhibit 38: Chart on Other infections - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Other infections - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by Type
• Exhibit 40: Market opportunity by Type ($ billion)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Japan - Market size and forecast 2021-2026
• Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
• Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
• Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
• 7.9 China - Market size and forecast 2021-2026
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.10 Germany - Market size and forecast 2021-2026
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.11 UK - Market size and forecast 2021-2026
• Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 82: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings
• 10.4 Aurobindo Pharma Ltd.
• Exhibit 92: Aurobindo Pharma Ltd. - Overview
• Exhibit 93: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 94: Aurobindo Pharma Ltd. - Key offerings
• 10.5 Bristol Myers Squibb Co.
• Exhibit 95: Bristol Myers Squibb Co. - Overview
• Exhibit 96: Bristol Myers Squibb Co. - Product / Service
• Exhibit 97: Bristol Myers Squibb Co. - Key offerings
• 10.6 C. H. Boehringer Sohn AG and Co. KG
• Exhibit 98: C. H. Boehringer Sohn AG and Co. KG - Overview
• Exhibit 99: C. H. Boehringer Sohn AG and Co. KG - Business segments
• Exhibit 100: C. H. Boehringer Sohn AG and Co. KG - Key news
• Exhibit 101: C. H. Boehringer Sohn AG and Co. KG - Key offerings
• Exhibit 102: C. H. Boehringer Sohn AG and Co. KG - Segment focus
• 10.7 Dynavax Technologies Corp.
• Exhibit 103: Dynavax Technologies Corp. - Overview
• Exhibit 104: Dynavax Technologies Corp. - Product / Service
• Exhibit 105: Dynavax Technologies Corp. - Key news
• Exhibit 106: Dynavax Technologies Corp. - Key offerings
• 10.8 F. Hoffmann La Roche Ltd.
• Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
• 10.9 Gilead Sciences Inc.
• Exhibit 112: Gilead Sciences Inc. - Overview
• Exhibit 113: Gilead Sciences Inc. - Product / Service
• Exhibit 114: Gilead Sciences Inc. - Key news
• Exhibit 115: Gilead Sciences Inc. - Key offerings
• 10.10 GlaxoSmithKline Plc
• Exhibit 116: GlaxoSmithKline Plc - Overview
• Exhibit 117: GlaxoSmithKline Plc - Business segments
• Exhibit 118: GlaxoSmithKline Plc - Key news
• Exhibit 119: GlaxoSmithKline Plc - Key offerings
• Exhibit 120: GlaxoSmithKline Plc - Segment focus
• 10.11 Johnson and Johnson
• Exhibit 121: Johnson and Johnson - Overview
• Exhibit 122: Johnson and Johnson - Business segments
• Exhibit 123: Johnson and Johnson - Key news
• Exhibit 124: Johnson and Johnson - Key offerings
• Exhibit 125: Johnson and Johnson - Segment focus
• 10.12 Merck and Co. Inc.
• Exhibit 126: Merck and Co. Inc. - Overview
• Exhibit 127: Merck and Co. Inc. - Business segments
• Exhibit 128: Merck and Co. Inc. - Key news
• Exhibit 129: Merck and Co. Inc. - Key offerings
• Exhibit 130: Merck and Co. Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 131: Inclusions checklist
• Exhibit 132: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 133: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 134: Research methodology
• Exhibit 135: Validation techniques employed for market sizing
• Exhibit 136: Information sources
• 11.5 List of abbreviations
• Exhibit 137: List of abbreviations